Beijing Pearl Biotechnology Limited Liability Company

This study is testing a new two-drug combination for people with a specific type of advanced lung cancer that has spread. The goal is to find a safe dose and see if the combination can help shrink tumors or stop them from growing. The trial is for adults whose cancer has a geneti…